https://www.nature.com/articles/d41586-023-02374-2 Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement Advertisement Nature * View all journals * Search * Log in * Explore content * About the journal * Publish with us * Subscribe * Sign up for alerts * RSS feed 1. nature 2. news 3. article * NEWS * 21 July 2023 Dementia risk linked to blood-protein imbalance in middle age Abnormal levels of certain proteins -- many of which have roles outside the brain -- could be an early hallmark of Alzheimer's disease or similar conditions. * Lilly Tozer 1. Lilly Tozer View author publications You can also search for this author in PubMed Google Scholar * Twitter * Facebook * Email You have full access to this article via your institution. Download PDF Visualization showing a brain affected by Alzheimer's disease. A slice through the brain of a person with Alzheimer's disease, the most common cause of dementia.Credit: Anatomical Travelogue/Science Photo Library A study that followed thousands of people over 25 years has identified proteins linked to the development of dementia if their levels are unbalanced during middle age. The findings, published in Science Translational Medicine on 19 July^ 1, could contribute to the development of new diagnostic tests, or even treatments, for dementia-causing diseases. Most of the proteins have functions unrelated to the brain. "We're seeing so much involvement of the peripheral biology decades before the typical onset of dementia," says study author Keenan Walker, a neuroscientist at the US National Institute on Aging in Bethesda, Maryland. [d41586-023] Conquering Alzheimer's: a look at the therapies of the future Equipped with blood samples from more than 10,000 participants, Walker and his colleagues questioned whether they could find predictors of dementia years before its onset by looking at a person's proteome -- the collection of all the proteins expressed throughout the body. They searched for any signs of dysregulation -- when proteins are at levels much higher or lower than normal. The samples were collected as part of an ongoing study that began in 1987. Participants returned for examination six times over three decades, and during this time, around 1 in 5 of them developed dementia. The researchers found 32 proteins that, if dysregulated in people aged 45 to 60, were strongly associated with an elevated chance of developing dementia in later life. It is unclear how exactly these proteins might be involved in the disease, but the link is "highly unlikely to be due to just chance alone", says Walker. "Not all the proteins showed changes in both plasma and brain tissues," says Nicholas Seyfried, a biochemist and neurologist at Emory University in Atlanta, Georgia. For example, one of the proteins found with the strongest association with dementia risk -- called GDF15 -- was not detected in the brain, suggesting that "mechanisms below the neck could also play a role", he adds. Walker says that although a person's proteome by itself cannot predict their risk of getting dementia, it could perhaps bolster the strength of existing predictors -- such as age and family history. Protein balance As expected, some of the proteins that researchers identified are active in the brain -- but most have other roles in the body. A handful were linked to proteostasis -- the process of carefully balancing protein levels in the proteome. This regulation is important in preventing proteins from going rogue and clumping together, which is what happens to the amyloid and tau proteins in the brains of people with Alzheimer's disease, the most common cause of dementia. [d41586-023] How to defeat dementia The study found altered levels of many of the proteins both in the brain tissues of those who had died with Alzheimer's disease, and in the blood of those still living with it. These were associated with the presence of amyloid and tau proteins, which suggests they are somehow involved in processes specific to the disease. Other proteins identified in the study were linked to the immune system, adding to "growing evidence for the role of innate and adaptive immune function in dementia", says Jin-Tai Yu, a physician-scientist who specializes in dementia at Fudan University in Shanghai, China. Yu and his team have previously found that people with immune diseases are more vulnerable to Alzheimer's later in life ^2. There is still a long way to go in understanding exactly how any of these proteins fit into the physiology of dementia, and a much better understanding of the underlying mechanisms is needed before people can benefit. Such insights "could potentially open doors for early interventions", says Seyfried. For Walker, the aim in future is to determine whether these proteins could potentially be used as markers to identify various dysregulated pathways in people with dementia and to help provide more personalized treatments. doi: https://doi.org/10.1038/d41586-023-02374-2 References 1. Walker, K. A. et al. Sci. Transl. Med. 15, eadf5681 (2023). Article PubMed Google Scholar 2. Zhang, Y.-R. et al. Alzheimers Res. Ther. 14, 130 (2022). Article PubMed Google Scholar Download references Reprints and Permissions Related Articles * [d41586-023] Alzheimer's drug donanemab helps most when taken at earliest disease stage, study finds * [d41586-023] Conquering Alzheimer's: a look at the therapies of the future * [d41586-023] Could COVID delirium bring on dementia? * [d41586-023] This is how an Alzheimer's gene ravages the brain * [d41586-023] How to defeat dementia * [d41586-023] How one man's rare Alzheimer's mutation delayed the onset of disease Subjects * Medical research * Proteomics * Alzheimer's disease * Brain Latest on: Medical research As COVID-19 cases rose, so did diabetes -- no one knows why As COVID-19 cases rose, so did diabetes -- no one knows why News 21 JUL 23 Had COVID but no symptoms? You might have this genetic mutation Had COVID but no symptoms? You might have this genetic mutation News 19 JUL 23 An atlas of healthy and injured cell states and niches in the human kidney An atlas of healthy and injured cell states and niches in the human kidney Article 19 JUL 23 Proteomics AI tools are designing entirely new proteins that could transform medicine AI tools are designing entirely new proteins that could transform medicine News Feature 11 JUL 23 Disrupting protein folding to tackle cancer Disrupting protein folding to tackle cancer Outlook 24 MAY 23 Astrocyte-neuron subproteomes and obsessive-compulsive disorder mechanisms Astrocyte-neuron subproteomes and obsessive-compulsive disorder mechanisms Article 12 APR 23 Nature Careers Jobs * Postdoctoral Position In Computational Psychiatry University of Alberta in Edmonton is recruiting two postdoctoral fellows in computational psychiatry Edmonton (City), Alberta (CA) University of Alberta [] * Head of Facility - National Facility for Genomics APPLICATION CLOSING DATE: September 1st, 2023. Human Technopole (HT) is a new interdisciplinary life science research institute, created and suppor... Milan (IT) Human Technopole [] * Head of Facility - National Facility for Light Imaging APPLICATION CLOSING DATE: September 1st, 2023. Human Technopole (HT) is a new interdisciplinary life science research institute, created and suppor... Milan (IT) Human Technopole [] * Call for applications: ISGlobal Director General The Barcelona Institute for Global Health, ISGlobal, ISGlobal is in search of an exceptional, globally acknowledged, and forward-thinking leader. Barcelona (Provincia), Cataluna (ES) ISGLOBAL [] * Open Rank Faculty Positions in Carbon Neutrality and Climate Change Thrust, HKUST(GZ) About HKUST(GZ) Formally established in June 2022, the Hong Kong University of Science and Technology(Guangzhou)(HKUST(GZ)) is a cooperatively-run ... Guangzhou, Guangdong (CN) The Hong Kong University of Science and Technology(Guangzhou) [] You have full access to this article via your institution. Download PDF Related Articles * [d41586-023] Alzheimer's drug donanemab helps most when taken at earliest disease stage, study finds * [d41586-023] Conquering Alzheimer's: a look at the therapies of the future * [d41586-023] Could COVID delirium bring on dementia? * [d41586-023] This is how an Alzheimer's gene ravages the brain * [d41586-023] How to defeat dementia * [d41586-023] How one man's rare Alzheimer's mutation delayed the onset of disease Subjects * Medical research * Proteomics * Alzheimer's disease * Brain Advertisement Sign up to Nature Briefing An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday. Email address [ ] [ ] Yes! Sign me up to receive the daily Nature Briefing email. I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy. Sign up * Close Nature Briefing Sign up for the Nature Briefing newsletter -- what matters in science, free to your inbox daily. Email address [ ] Sign up [ ] I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy. Close Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing Explore content * Research articles * News * Opinion * Research Analysis * Careers * Books & Culture * Podcasts * Videos * Current issue * Browse issues * Collections * Subjects * Follow us on Facebook * Follow us on Twitter * Subscribe * Sign up for alerts * RSS feed About the journal * Journal Staff * About the Editors * Journal Information * Our publishing models * Editorial Values Statement * Journal Metrics * Awards * Contact * Editorial policies * History of Nature * Send a news tip Publish with us * For Authors * For Referees * Language editing services * Submit manuscript Search Search articles by subject, keyword or author [ ] Show results from [All journals] Search Advanced search Quick links * Explore articles by subject * Find a job * Guide to authors * Editorial policies Nature (Nature) ISSN 1476-4687 (online) ISSN 0028-0836 (print) nature.com sitemap About Nature Portfolio * About us * Press releases * Press office * Contact us Discover content * Journals A-Z * Articles by subject * Nano * Protocol Exchange * Nature Index Publishing policies * Nature portfolio policies * Open access Author & Researcher services * Reprints & permissions * Research data * Language editing * Scientific editing * Nature Masterclasses * Live Expert Trainer-led workshops * Research Solutions Libraries & institutions * Librarian service & tools * Librarian portal * Open research * Recommend to library Advertising & partnerships * Advertising * Partnerships & Services * Media kits * Branded content Career development * Nature Careers * Nature Conferences * Nature events Regional websites * Nature Africa * Nature China * Nature India * Nature Italy * Nature Japan * Nature Korea * Nature Middle East * Privacy Policy * Use of cookies * Your privacy choices/Manage cookies * Legal notice * Accessibility statement * Terms & Conditions * Your US state privacy rights Springer Nature (c) 2023 Springer Nature Limited